Scientists have found that the use of bisphosphonates - drugs already taken by millions of healthy women to prevent bone-loss - for more than one year is associated with a 50 per cent reduction in the risk of postmenopausal colorectal cancer.
The result remain the same even after making adjustments for a large variety of known risk or protective factors for colorectal cancer such as family history, dietary components, physical activity, body mass index, and the use of other medications such as aspirin, statins and hormone replacement therapy. The results were published this week in the Journal of Clinical Oncology. ANI
`Govt plans Waterport Authority of India`
Hearing on Anderson-Jadeja spat set for Aug 1
Hamas uses donkey to attack Israeli troops
Don`t take us for granted, NCP warns Congress